Navigation Links
BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday, July 30 at 5:00 p.m. ET (23:00 CET)
Date:7/1/2009

NOVATO, Calif., July 1 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, July 30, at 5:00 p.m. ET (23:00 CET) to discuss second quarter 2009 financial results.

    U.S. / Canada Dial-in Number:  866.272.9941
    International Dial-in Number:  617.213.8895
    Participant Code: 45596036
    Replay Dial-in Number: 888.286.8010
    Replay International Dial-in Number: 617.801.6888
    Replay Code: 74141589

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is in clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase 1/2 clinical d
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. BioMarin to Present at the Bear Stearns 20th Annual Healthcare Conference
2. BioMarin Provides Grant to NORD to Expand PKU Patient Support Services
3. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
4. Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
5. BioMarin to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast on Tuesday, February 26 at 5:00 p.m. ET (23:00 CET)
6. BioMarin to Present at the Cowen and Company 28th Annual Healthcare Conference
7. BioMarin to Present at the Lehman Brothers Global Healthcare Conference
8. BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
9. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
10. BioMarin to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. BioMarin Supports Observance of Rare Disease Day February 28

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...roving true the old adage that "The sum is greater...spital Southlake (THHMHS) is partnering with the U... make the holiday season a little brighter for man...their efforts to collect unwrapped toys and canned...ating in a final event on Tuesday, December 8th ...
(Date:12/2/2009)... risk is unclear , , WEDNESDAY, Dec. 2 (... that the average cigarette is crawling with germs...e. , But as one spokesman for a tobacco company...sure what, if any, hazard the germs pose. And expo... us every day of our lives. , Still, the findi...
(Date:12/2/2009)... youths are more likely to be advertised in magazi...ks consumed mainly by adults, resulting in disprop...lcohol ads, according to a new study. , Research...th, Johns Hopkins Bloomberg School of Public Healt...tudy -- published in this month,s issue of the J...
(Date:12/2/2009)...es in the battle against drug abuse, but new resea...tudy dozens of human disease could claim that rol...e used as a simpler and more convenient animal mod...rugs of abuse on the brain. Their study appears on... journal. , Andrew Ewing and colleagues note th...
(Date:12/2/2009)... cholesterol and become obese? The same way as peo..., More importantly, according to two new studies...it flies use the same molecular mechanisms as huma... and a key form of stored fat that contributes to ... to learn more about the genetic and biological pr...
Breaking Medicine News(10 mins):Health News:Texas Health Harris Methodist Hospital Southlake Joins With U.S. Marine Corps Reserves Toys for Tots to Spread Holiday Cheer 2Health News:Smokers Inhaling Germs With Each Cigarette 2Health News:Alcohol companies target youths with magazine ads, new study shows 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3
...ogram called Headspace is being introduced by the ...ntervention and treatment for youngsters whose men...gnored. Establishment of 30 centres across t...ional Youth Mental Health Foundation's Advisory Bo...
...studies of immigrant farmworker families in North ...exposure in young children// , and prompted resear...rkers’ spouses. In the American Journal of In...ticide exposure than had been found in similar stu...
...h Korean electronics giant Samsung has developed a...or//. The device has four electrodes that the...h hand. These send a safe current through the body...hich is known to cause many adult diseases. ...
...rding to the parliament's Health Select Committee ...in England needs to be reviewed//. It pointed ..., dentistry and eye care do not have any comprehen...fect on the patients and the evidence for this fac...
...nese chemicals and pharmaceutical companies have e...of Mitsubishi Chemicals Co already committing Rs 1...s Haldia unit // , Union Chemicals and Fertilisers... Japanese Pharmaceutical Industry Association (JPI...
...s not uncommon to have testimonies of surgeries - ...hin patients' bodies, a stark reminder of medical/...ions and even death of unfortunate patients. Stati...icknamed as the 'magic wand' which will ensure sur...
Other Medicine News:Health News:Research Documents Children’s Exposure to Pesticide 2
(Date:12/2/2009)...-- Laser Spine Institute (LSI), the leader in mi...nounce a partnership with United Healthcare and af... and clinical review process. Laser Spine Institut...invasive spinal surgery to ever contract with Unit...h United Healthcare may be covered for qualified n...
(Date:12/2/2009)...swire-FirstCall/ -- American Scientific Resources...es that the Disintegrator Plus(TM), the world,s on...D), is in its first production run for ASR. ,,...for home injection prescription drug users in Cali...SB 486 which requires Californian,s to safely dis...
(Date:12/2/2009)...mber 2 DermaGen AB - part of the,K...g company "Pergamum" -,today announced that Dermag...al Phase I/IIa study. DermaGen AB is developing a ...opic dermatitis. Atopic dermatitis is a chronic,in...n,s weakened barrier,function make patients suscep...
Breaking Medicine Technology:Laser Spine Institute Partners with United Healthcare 2Laser Spine Institute Partners with United Healthcare 3World's Only FDA Approved Home Needle Destruction Device is in Production 2World's Only FDA Approved Home Needle Destruction Device is in Production 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Agricultural research key to food security 9469 1Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 1Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 2Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 3Ferring Pharmaceuticals Announces Trade Name FIRMAGON 28R 29 28degarelix for injection 29 for Advanced Prostate Cancer Treatment 53625 4New Collagen Meniscus Implant Opens New Vista for Knee Repair 53621 1New Collagen Meniscus Implant Opens New Vista for Knee Repair 53621 2New Collagen Meniscus Implant Opens New Vista for Knee Repair 53621 3New Collagen Meniscus Implant Opens New Vista for Knee Repair 53621 4
...tritech, Inc. announced the upcoming,presentation ...HMAN(R) Left,Atrial Appendage (LAA) Closure Device... in patients with non-valvular atrial fibrillation...ng Clinical Trial session during,the I2 Summit Sci... I2 Summit,is part of the Annual Meeting of the Am...
...d WATERTOWN, Mass., Feb. 18 ,Abbott ( NYSE: ABT ) ...ancement,of their Hepatitis C (HCV) collaboration ... oral protease inhibitor for the treatment of chro...ssment of safety, tolerability,and pharmacokinetic...alliance,between Abbott and Enanta to discover, de...
Other Medicine Technology:Atritech to Participate in Late-Breaking Clinical Trial Presentation at American College of Cardiology Meeting 2Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor 2Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor 3
BirdBeak Suture Passer, Straight
...d suture to be used in arthroscopic soft tissue re...size of suture material and in conjunction with an... an anchor) Additionally, the Shuttle Relay can b...urepassing,instrument, including a suture punch, s...
Revo Rotator Cuff Repair System
CuffTack Anchor and Instrumentation
Medicine Products: